08.00-09.30   FORUM


Therapies for ADPKD


Chairs: Dorien Peters, Leiden, The Netherlands
            Piero Ruggenenti, Bergamo, Italy


Vasopressin V2 receptor antagonists for renoprotection in ADPKD

Ron T. Gansevoort, Groningen, Netherlands

Somatostatin therapy

Piero Ruggenenti, Bergamo, Italy

Targeted tyrosine kinase inhibition in ADPKD: a therapeutic option?

Dominique Chauveau, Toulouse, France


back to the timetable